Author:
Rosato L.,Raffaelli M.,Bellantone R.,Pontecorvi A.,Avenia N.,Boniardi M.,Brandi M. L.,Cetani F.,Chiofalo M. G.,Conzo G.,De Palma M.,Gasparri G.,Giordano A.,Innaro N.,Leopaldi E.,Mariani G.,Marcocci C.,Marini P.,Miccoli P.,Nasi P.,Pacini F.,Paragliola R.,Pelizzo M. R.,Testini M.,De Toma G.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference56 articles.
1. Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17(Suppl 2):N18–N23
2. Conference NIH (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism––consensus development conference statement. Ann Intern Med 114:593–597
3. Bilezikian JP, Potts JT Jr, El-Hajj Fuleihan G et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353–5361
4. Messa P, Italian Society of Nephrology (2003) Renal osteodystrophy guidelines. G Ital Nefrol 20(Suppl 24):S83–S95
5. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献